United States · FDA National Drug Code directory
LOKELMA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0310-1110_e97b97a9-6ad1-4b47-a5be-fefd7be47c23
- Product NDC
- 0310-1110
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- sodium zirconium cyclosilicate
- Labeler
- AstraZeneca Pharmaceuticals LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180904
- Source listing expiry
- 20261231
Source-listed ingredients
- SODIUM ZIRCONIUM CYCLOSILICATE — 10 g/10g
These values do not establish equivalence or a dose recommendation.
Packages
- 30 PACKET in 1 BOX (0310-1110-30) / 10 g in 1 PACKET (0310-1110-01) · 0310-1110-30
- 11 PACKET in 1 BOX (0310-1110-39) / 10 g in 1 PACKET (0310-1110-01) · 0310-1110-39
- 3 PACKET in 1 BOX (0310-1110-93) / 10 g in 1 PACKET (0310-1110-91) · 0310-1110-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →